Ningbo Menovo Pharmaceutical Co Ltd - ESG Rating & Company Profile powered by AI
This assessment of Ningbo Menovo Pharmaceutical Co Ltd employs information from across the internet as well as from public documents by Ningbo Menovo Pharmaceutical Co Ltd. Alternative corporations in the rating industry group for Ningbo Menovo Pharmaceutical Co Ltd are displayed below. The report of Ningbo Menovo Pharmaceutical Co Ltd is prepared by All Street Sevva using leading Cognitive Robots.
Ningbo Menovo Pharmaceutical Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Ningbo Menovo Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Ningbo Menovo Pharmaceutical Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Ningbo Menovo Pharmaceutical Co Ltd disclose current and historical energy intensity?
Does Ningbo Menovo Pharmaceutical Co Ltd report the average age of the workforce?
Does Ningbo Menovo Pharmaceutical Co Ltd reference operational or capital allocation in relation to climate change?
Does Ningbo Menovo Pharmaceutical Co Ltd disclose its ethnicity pay gap?
Does Ningbo Menovo Pharmaceutical Co Ltd disclose cybersecurity risks?
Does Ningbo Menovo Pharmaceutical Co Ltd offer flexible work?
Does Ningbo Menovo Pharmaceutical Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Ningbo Menovo Pharmaceutical Co Ltd disclose the number of employees in R&D functions?
Does Ningbo Menovo Pharmaceutical Co Ltd conduct supply chain audits?
Does Ningbo Menovo Pharmaceutical Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Ningbo Menovo Pharmaceutical Co Ltd conduct 360 degree staff reviews?
Does Ningbo Menovo Pharmaceutical Co Ltd disclose the individual responsible for D&I?
Does Ningbo Menovo Pharmaceutical Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Ningbo Menovo Pharmaceutical Co Ltd disclose current and / or historical scope 2 emissions?
Does Ningbo Menovo Pharmaceutical Co Ltd disclose water use targets?
Does Ningbo Menovo Pharmaceutical Co Ltd have careers partnerships with academic institutions?
Did Ningbo Menovo Pharmaceutical Co Ltd have a product recall in the last two years?
Does Ningbo Menovo Pharmaceutical Co Ltd disclose incidents of discrimination?
Does Ningbo Menovo Pharmaceutical Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Ningbo Menovo Pharmaceutical Co Ltd issued a profit warning in the past 24 months?
Does Ningbo Menovo Pharmaceutical Co Ltd disclose parental leave metrics?
Does Ningbo Menovo Pharmaceutical Co Ltd disclose climate scenario or pathway analysis?
Does Ningbo Menovo Pharmaceutical Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Ningbo Menovo Pharmaceutical Co Ltd disclose the pay ratio of women to men?
Does Ningbo Menovo Pharmaceutical Co Ltd support suppliers with sustainability related research and development?
Does Ningbo Menovo Pharmaceutical Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Ningbo Menovo Pharmaceutical Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Ningbo Menovo Pharmaceutical Co Ltd involved in embryonic stem cell research?
Does Ningbo Menovo Pharmaceutical Co Ltd disclose GHG and Air Emissions intensity?
Does Ningbo Menovo Pharmaceutical Co Ltd disclose its waste policy?
Does Ningbo Menovo Pharmaceutical Co Ltd report according to TCFD requirements?
Does Ningbo Menovo Pharmaceutical Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Ningbo Menovo Pharmaceutical Co Ltd disclose energy use targets?
Does Ningbo Menovo Pharmaceutical Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Ningbo Menovo Pharmaceutical Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Ningbo Menovo Pharmaceutical Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products. It offers APIs, intermediates, and formulations for the treatment of cardiovascular, central nervous, respiratory, antitumor, anti-infection, digestive, and geriatric diseases, as well as antiviral. The company was founded in 2004 and is headquartered in Ningbo, China.